Literature DB >> 12217281

Early results of thrombolysis vs anticoagulation in iliofemoral venous thrombosis. A randomised clinical trial.

M Elsharawy1, E Elzayat.   

Abstract

OBJECTIVE: catheter directed thrombolysis has been advocated for complete and rapid dissolution of iliofemoral deep venous thrombosis (DVT). The aim of our study is to compare, in a randomised trial, local thrombolysis and anticoagulation with anticoagulation alone in patients with iliofemoral DVT.
METHODS: a consecutive series of 35 eligible patients, were randomised to either catheter directed thrombolysis followed by anticoagulation or to anticoagulation alone. Clot lysis and deep venous reflux were assessed with ultrasound duplex and plethysmography after 6 months.
RESULTS: complete data were available in the 18 and 17 patients randomised to thrombolysis and anticoagulation, respectively. At 6 months, patency rate was better in cases treated with thrombolysis [13/18 (72%) vs 2/17 (12%), p < 0.001]. Venous reflux was higher in-patients treated with anticoagulant [7 patients (41%) vs 2 (11%), p = 0.04].
CONCLUSION: in the short-term patients treated with catheter directed thrombolysis obtained better patency and competence than those treated with standard anticoagulation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12217281     DOI: 10.1053/ejvs.2002.1665

Source DB:  PubMed          Journal:  Eur J Vasc Endovasc Surg        ISSN: 1078-5884            Impact factor:   7.069


  50 in total

Review 1.  How We Manage Pediatric Deep Venous Thrombosis.

Authors:  Marisol Betensky; Mark A Bittles; Paul Colombani; Neil A Goldenberg
Journal:  Semin Intervent Radiol       Date:  2017-03       Impact factor: 1.513

2.  Iliocaval vein stenting: Long term survey of postthrombotic symptoms and working capacity.

Authors:  Alaa Alhadad; Tilo Kölbel; Andreas Herbst; Jan Holst; Hussein Alhadad; Anders Gottsäter
Journal:  J Thromb Thrombolysis       Date:  2011-02       Impact factor: 2.300

3.  Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Clive Kearon; Elie A Akl; Anthony J Comerota; Paolo Prandoni; Henri Bounameaux; Samuel Z Goldhaber; Michael E Nelson; Philip S Wells; Michael K Gould; Francesco Dentali; Mark Crowther; Susan R Kahn
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

4.  Thrombolytic therapy for deep vein thrombosis.

Authors:  Suresh Vedantham
Journal:  Curr Treat Options Cardiovasc Med       Date:  2009-04

5.  57-year-old woman with acute lower extremity pain and swelling.

Authors:  Elizabeth Coss; Jeffrey B Geske; Paul S Mueller
Journal:  Mayo Clin Proc       Date:  2009-10       Impact factor: 7.616

Review 6.  Catheter-directed thrombolysis of deep vein thrombosis: literature review and practice considerations.

Authors:  Drew Fleck; Hassan Albadawi; Fadi Shamoun; Grace Knuttinen; Sailendra Naidu; Rahmi Oklu
Journal:  Cardiovasc Diagn Ther       Date:  2017-12

7.  Thrombolytics for venous thromboembolic events: a systematic review with meta-analysis.

Authors:  Ariel Izcovich; Juan M Criniti; Federico Popoff; Liming Lu; Jiaming Wu; Walter Ageno; Daniel M Witt; Michael R Jaff; Sam Schulman; Veena Manja; Peter Verhamme; Gabriel Rada; Yuqing Zhang; Robby Nieuwlaat; Wojtek Wiercioch; Holger J Schünemann; Ignacio Neumann
Journal:  Blood Adv       Date:  2020-04-14

8.  Efficacy and Safety of Catheter-directed Thrombolysis in Preventing Post-thrombotic Syndrome: A Meta-analysis.

Authors:  Luai Alhazmi; Abdelmoneim Moustafa; Muhammad A Mangi; Ahmed Alamer; Ehab Eltahawy
Journal:  Cureus       Date:  2019-02-28

9.  Catheter-Directed Thrombolysis Along with Mechanical Thromboaspiration versus Anticoagulation Alone in the Management of Lower Limb Deep Venous Thrombosis-A Comparative Study.

Authors:  B C Srinivas; Soumya Patra; C M Nagesh; Babu Reddy; C N Manjunath
Journal:  Int J Angiol       Date:  2014-12

10.  Cost-effectiveness of additional catheter-directed thrombolysis for deep vein thrombosis.

Authors:  T Enden; S Resch; C White; H S Wik; N E Kløw; P M Sandset
Journal:  J Thromb Haemost       Date:  2013-06       Impact factor: 5.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.